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A Word of Caution*Barry T. Katzen, MDI n this issue of the Journal, Al-Damluji et al. (1)present their ﬁndings culled from a detailedevaluation of the Centers for Medicare and
Medicaid Services database. Through their study,
the authors have done an outstanding job in high-
lighting a subject of increasing importance in clinical
care, namely, readmission rates following the perfor-
mance of fairly common procedures of revasculariza-
tion of the carotid artery in the Medicare population.
Readmissions are increasingly being monitored as
a benchmark of both the quality of and the costs to
the health care system. As such, identifying diseases
and procedures that are associated with signiﬁcant
readmission rates allows physicians and administra-
tors to focus attention on identifying variables and
creating opportunities for improvement in the man-
agement of these patients.SEE PAGE 1398The authors’ ﬁrst observation was a nearly 10%
rate of 30-day readmissions in patients undergoing
carotid revascularization. This number might seem
surprisingly high and points to the value of database
mining for this type of information. This impor-
tant observation presents a strong clinical target to be
measured and on which to improve outcomes. In*Editorials published in the Journal of the American College of Cardiology
reﬂect the views of the authors and do not necessarily represent the
views of JACC or the American College of Cardiology.
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Boston Scientiﬁc.particular, the authors identify that the causes of
readmission were diverse and related to multiple
comorbidities, the great majority being unrelated to
neurological events or injuries. In fact, the top 10
causes of readmission accounted for only 50% of the
readmissions, challenging practitioners who focus on
only 1 area to take a close look at readmission rates in
their own institutions.
The increased readmission rate across virtually
all categories of patients, both symptomatic and
asymptomatic, including all age groups and sex dif-
ferences, is an interesting observation but may be
contributed to by a number of mitigating factors.
This study was based on data from a fee-for-service
database that includes an estimated 70% of the
Medicare population; this criterion may have resulted
in selection biases in terms of patient selection and
delivery of service. By Medicare criteria, carotid ar-
tery stenting (CAS) is principally performed in
symptomatic patients at “high risk for carotid end-
arterectomy (CEA)” or in asymptomatic patients
enrolled in US Food and Drug Administration–
approved high-risk clinical trials or registries (90% of
the CAS patients in the database). While propensity
score matching methodologies are statistically
designed to create similar groups, the authors men-
tion that limitations of the study included variabil-
ities in coding, planned readmissions that could not
be differentiated from unplanned readmissions, and,
importantly, the lack of randomization, which can
add confounds to the data analysis, as well as the
lack of any correlation with the outcomes of clinical
procedures during the index hospitalization. As
the authors state, “The patients in our cohort were
not randomized to the carotid revascularization
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1410strategies, and as a result, residual confounds may be
present in our observed association despite the use of
propensity score matching.” In this regard, in the
matched cohort of patients—32,119 patients in each
group—of course represent almost all of the CAS pa-
tients and a much smaller percentage of the CEA
patients.
As a result, the reader should be wary of drawing
the conclusion that CAS is “higher risk” than is CEA
because of the earlier mentioned issues; despite
propensity scoring, there still may have been signiﬁ-
cant variations between the two groups. Importantly,
post-procedural stroke rates in the 30-day period
were low in both groups. CEA and CAS are bothperformed to reduce the risks for stroke and death
related to extracranial atherosclerosis, and it is these
factors that remain most important in comparing
procedure alternatives.
The authors should be congratulated for this
extensive analysis, which successfully points out an
important opportunity for the medical community to
further study the prevalence of readmission rates in
carotid revascularization.
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